Neurogene Inc.
Key Metrics
Market Snapshot
About
Neurogene Inc. is a clinical-stage biotechnology company developing gene therapies for rare neurological diseases. The company focuses on adeno-associated virus (AAV)-based gene therapies targeting conditions like Rett syndrome and other genetic neurological disorders. Neurogene uses its proprietary EXACT platform to deliver therapeutic genes directly to the central nervous system.